STOCK TITAN

Co-Diagnostics, Inc. to Host Booth at 67th Annual CARPHA Conference April 27-29

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SALT LAKE CITY, April 26, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the Caribbean Public Health Agency (CARPHA) 67th Annual Health Research Conference, being held in-person April 27-29, 2023, in the Bahamas.

The CARPHA Annual Health Research Conference is the largest health research conference in the English-speaking Caribbean and the longest-running health research Conference in Latin America and the Caribbean region, with the goal of facilitating and promoting communication and sharing of scientific outputs among health scientists, policymakers, and related professionals in the wider Caribbean Region.

The Company's booth will showcase Co-Diagnostics' infectious disease and vector control products to conference attendees, along with its upcoming Co-Dx PCR Home™ testing platform*. Co-Dx has had several important relationships in the Caribbean basin and has regularly attended the annual CARPHA conference since 2016.

More information about the conference may be found here. Attendees interested in learning more about the Company and its products, including its upcoming Co-Dx PCR Home platform, are invited to visit the Company's booth.

*The Co-Dx PCR Home platform is subject to FDA review and is not available for sale.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-67th-annual-carpha-conference-april-27-29-301807986.html

SOURCE Co-Diagnostics

Co-Diagnostics, Inc.

NASDAQ:CODX

CODX Rankings

CODX Latest News

CODX Stock Data

37.51M
30.41M
2.68%
15.77%
1.59%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SALT LAKE CITY

About CODX

co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are